Serum heavy metals and breast cancer risk: A case-control study nested in the Florence cohort of the EPIC (European Prospective Investigation into Cancer and nutrition) study.

Breast cancer Cadmium Chromium Cobalt Heavy metals Lead Manganese Nested case-control study Thallium Vitamin B(12)

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
25 Feb 2023
Historique:
received: 12 10 2022
revised: 25 11 2022
accepted: 25 11 2022
pubmed: 5 12 2022
medline: 17 1 2023
entrez: 4 12 2022
Statut: ppublish

Résumé

Chronic exposure to heavy metals is of concern for its potential carcinogenic effect. An association with increased breast cancer (BC) risk was hypothesized, but literature data are conflicting and the question remains unresolved. We aimed to investigate the association between heavy metals and BC risk in a case-control study nested within the Florence section of the EPIC (European Prospective Investigation into Cancer and nutrition) cohort. We included 150 BC cases and an equal number of controls individually matched to cases by age and year of enrolment. In order to avoid confounding by smoking, the study was restricted to never smokers. Serum levels of six heavy metals (Cd, Co, Cr, Mn, Pb, and Tl) were quantified in pre-diagnostic samples using inductively coupled plasma mass spectrometry. Odds ratios (ORs) and corresponding 95 % confidence intervals (CI) were calculated via multivariable conditional logistic regression models. Serum levels of cobalt were inversely associated with BC risk (OR for the comparison of 3rd vs. 1st tertiles: 0.33, 95 % CI 0.12-0.91, p-value 0.033). None of the other heavy metals under study was significantly associated with BC risk in multivariable models. For Cd, Cr, and Tl, over half of the study participants had serum levels below the limit of quantitation. Our results do not support the hypothesis that exposure to heavy metals is associated with an increased BC risk among never smokers from the general population. The inverse association between cobalt serum levels and BC risk requires confirmation in future studies.

Sections du résumé

BACKGROUND BACKGROUND
Chronic exposure to heavy metals is of concern for its potential carcinogenic effect. An association with increased breast cancer (BC) risk was hypothesized, but literature data are conflicting and the question remains unresolved. We aimed to investigate the association between heavy metals and BC risk in a case-control study nested within the Florence section of the EPIC (European Prospective Investigation into Cancer and nutrition) cohort.
METHODS METHODS
We included 150 BC cases and an equal number of controls individually matched to cases by age and year of enrolment. In order to avoid confounding by smoking, the study was restricted to never smokers. Serum levels of six heavy metals (Cd, Co, Cr, Mn, Pb, and Tl) were quantified in pre-diagnostic samples using inductively coupled plasma mass spectrometry. Odds ratios (ORs) and corresponding 95 % confidence intervals (CI) were calculated via multivariable conditional logistic regression models.
RESULTS RESULTS
Serum levels of cobalt were inversely associated with BC risk (OR for the comparison of 3rd vs. 1st tertiles: 0.33, 95 % CI 0.12-0.91, p-value 0.033). None of the other heavy metals under study was significantly associated with BC risk in multivariable models. For Cd, Cr, and Tl, over half of the study participants had serum levels below the limit of quantitation.
CONCLUSIONS CONCLUSIONS
Our results do not support the hypothesis that exposure to heavy metals is associated with an increased BC risk among never smokers from the general population. The inverse association between cobalt serum levels and BC risk requires confirmation in future studies.

Identifiants

pubmed: 36464039
pii: S0048-9697(22)07671-9
doi: 10.1016/j.scitotenv.2022.160568
pii:
doi:

Substances chimiques

Cadmium 00BH33GNGH
Metals, Heavy 0
Cobalt 3G0H8C9362

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160568

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All Authors have no competing interests to declare.

Auteurs

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: s.caini@ispro.toscana.it.

Flavia Cozzolino (F)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: f.cozzolino@ispro.toscana.it.

Calogero Saieva (C)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: c.saieva@ispro.toscana.it.

Maria Cristina Aprea (MC)

Unit of Occupational and Environmental Toxicology - Public Health Laboratory, Department of Prevention, AUSL South-East Tuscany, Strada del Ruffolo 4, 53100 Siena, Italy. Electronic address: cristina.aprea@uslsudest.toscana.it.

Nora De Bonfioli Cavalcabo' (N)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: n.debonfiolicavalcabo@ispro.toscana.it.

Ilaria Ermini (I)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: i.ermini@ispro.toscana.it.

Melania Assedi (M)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: m.assedi@ispro.toscana.it.

Davide Biagiotti (D)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: d.biagiotti@ispro.toscana.it.

Cinzia Trane (C)

Public Health Laboratory, Department of Technical Health Professions, Rehabilitation and Prevention, AUSL South-East Tuscany, Strada del Ruffolo 4, 53100 Siena, Italy. Electronic address: cinzia.trane@uslsudest.toscana.it.

Luigi Facchini (L)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: l.facchini@ispro.toscana.it.

Benedetta Bendinelli (B)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: b.bendinelli@ispro.toscana.it.

Domenico Palli (D)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: d.palli@ispro.toscana.it.

Giovanna Masala (G)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo Il Vecchio 2, 50139 Florence, Italy. Electronic address: g.masala@ispro.toscana.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH